prolylarginine has been researched along with arginine in 2 studies
Studies (prolylarginine) | Trials (prolylarginine) | Recent Studies (post-2010) (prolylarginine) | Studies (arginine) | Trials (arginine) | Recent Studies (post-2010) (arginine) |
---|---|---|---|---|---|
11 | 0 | 5 | 46,388 | 1,688 | 11,176 |
Protein | Taxonomy | prolylarginine (IC50) | arginine (IC50) |
---|---|---|---|
Cationic amino acid transporter 3 | Homo sapiens (human) | 283 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
De Marco, R; Di Gioia, ML; Leggio, A; Liguori, A; Perri, F; Siciliano, C; Viscomi, MC | 1 |
Chen, C; Harada, Y; Hayamizu, Y; Kanekura, K; Kuroda, M; Li, P; Miyagi, T; Narumi, S; Sugimoto, M; Tezuka, S; Ueda, K; Yamanaka, Y | 1 |
2 other study(ies) available for prolylarginine and arginine
Article | Year |
---|---|
A new non-natural arginine-like amino acid derivative with a sulfamoyl group in the side-chain.
Topics: Anticoagulants; Arginine; Dipeptides; Drug Design; Humans; Hydrogen Bonding; Oligopeptides; Ornithine; Partial Thromboplastin Time; Sulfonamides; Thrombin; Thrombin Time | 2010 |
Phase separation and toxicity of C9orf72 poly(PR) depends on alternate distribution of arginine.
Topics: Amyotrophic Lateral Sclerosis; Arginine; C9orf72 Protein; Cell Line; Cell Nucleolus; Dipeptides; HEK293 Cells; Humans; Peptides; Proteomics | 2021 |